J Reconstr Microsurg 2020; 36(02): 136-141
DOI: 10.1055/s-0039-1697904
Original Article
Thieme Medical Publishers 333 Seventh Avenue, New York, NY 10001, USA.

Uncovering Lymphatic Transport Abnormalities in Patients with Primary Lipedema

Daniel J. Gould
1   Division of Plastic and Reconstructive Surgery, Keck School of Medicine of University of Southern California, Los Angeles, California
,
Bassim El-Sabawi
1   Division of Plastic and Reconstructive Surgery, Keck School of Medicine of University of Southern California, Los Angeles, California
,
Pedram Goel
1   Division of Plastic and Reconstructive Surgery, Keck School of Medicine of University of Southern California, Los Angeles, California
,
Ido Badash
1   Division of Plastic and Reconstructive Surgery, Keck School of Medicine of University of Southern California, Los Angeles, California
,
Patrick Colletti
2   Department of Radiology, Keck School of Medicine of University of Southern California, Los Angeles, California
,
Ketan M. Patel
1   Division of Plastic and Reconstructive Surgery, Keck School of Medicine of University of Southern California, Los Angeles, California
› Author Affiliations
Funding None.
Further Information

Publication History

10 December 2018

20 August 2019

Publication Date:
23 September 2019 (online)

Abstract

Background Although lipedema is often clinically distinguished from lymphedema, there is considerable overlap between the two entities. The purpose of this study was to evaluate lymphoscintigraphic findings in patients with lipedema to better characterize lymphatic flow in this patient population.

Methods Patients with lipedema receiving lymphoscintigraphy between January 2015 and October 2017 were included. Patient demographics, clinical characteristics, and lymphoscintigraphic findings were extracted. Klienhan's transport index (TI) was utilized to assess lymphatic flow in patient's lower extremities (LEs).Scores ranged from 0 to 45, with values > 10 denoting pathologic lymphatic transport.

Results A total of 19 total patients with lipedema underwent lymphoscintigraphic evaluation. Mean age was 54.8 years and mean body mass index was 35.9 kg/m2. Severity of lipedema was classified as stage 1 in five patients (26.3%), stage 2 in four patients (21.1%), stage 3 in four patients (21.1%), and stage 4 in six patients (31.6%). The mean TI for all extremities was 12.5; 24 (63.2%) LEs had a pathologic TI, including 7 LEs with stage 1 (29.2%), 3 LEs with stage 2 (12.5%), 6 LEs with stage 3 (25.0%), and 8 LEs with stage 4 lipedema (33.3%). The mean TI was significantly greater for extremities with severe (stage 3/4) lipedema than those with mild or moderate (stage 1/2) lipedema (15.1 vs. 9.7, p = 0.049). Mean difference in TI scores between each LE for individual patients was 6.43 (standard deviation +7.96).

Conclusion Our results suggest that patients with lipedema have impaired lymphatic transport, and more severe lipedema may be associated with greater lymphatic transport abnormalities.

Note

This study was presented at the Plastic Surgery the Meeting in Orlando, Florida, October 6–10, 2017.


 
  • References

  • 1 Wold LE, Hines Jr EA, Allen EV. Lipedema of the legs; a syndrome characterized by fat legs and edema. Ann Intern Med 1951; 34 (05) 1243-1250
  • 2 Foldi E, Foldi M. Lipedema. In: Foldi M, Foldi E. , eds. Foldi's Textbook of Lymphology, 2nd ed. Munich: Elsevier GmbH; 2006: 417-427
  • 3 Buck II DW, Herbst KL. Lipedema: arelatively common disease with extremely common misconceptions. Plast Reconstr Surg Glob Open 2016; 4 (09) e1043
  • 4 Szél E, Kemény L, Groma G, Szolnoky G. Pathophysiological dilemmas of lipedema. Med Hypotheses 2014; 83 (05) 599-606
  • 5 Stallworth JM, Hennigar GR, Jonsson Jr HT, Rodriguez O. The chronically swollen painful extremity. A detailed study for possible etiological factors. JAMA 1974; 228 (13) 1656-1659
  • 6 Greer KE. Lipedema of the legs. Cutis 1974; 14: 98-100
  • 7 Amann-Vesti BR, Franzeck UK, Bollinger A. Microlymphatic aneurysms in patients with lipedema. Lymphology 2001; 34 (04) 170-175
  • 8 Schneider M, Conway EM, Carmeliet P. Lymph makes you fat. Nat Genet 2005; 37 (10) 1023-1024
  • 9 Harwood CA, Bull RH, Evans J, Mortimer PS. Lymphatic and venous function in lipoedema. Br J Dermatol 1996; 134 (01) 1-6
  • 10 Bräutigam P, Földi E, Schaiper I, Krause T, Vanscheidt W, Moser E. Analysis of lymphatic drainage in various forms of leg edema using two compartment lymphoscintigraphy. Lymphology 1998; 31 (02) 43-55
  • 11 Bilancini S, Lucchi M, Tucci S, Eleuteri P. Functional lymphatic alterations in patients suffering from lipedema. Angiology 1995; 46 (04) 333-339
  • 12 Kleinhans E, Baumeister RG, Hahn D, Siuda S, Büll U, Moser E. Evaluation of transport kinetics in lymphoscintigraphy: follow-up study in patients with transplanted lymphatic vessels. Eur J Nucl Med 1985; 10 (7–8): 349-352
  • 13 Cambria RA, Gloviczki P, Naessens JM, Wahner HW. Noninvasive evaluation of the lymphatic system with lymphoscintigraphy: a prospective, semiquantitative analysis in 386 extremities. J Vasc Surg 1993; 18 (05) 773-782
  • 14 Lohrmann C, Foeldi E, Langer M. MR imaging of the lymphatic system in patients with lipedema and lipo-lymphedema. Microvasc Res 2009; 77 (03) 335-339
  • 15 Okhovat JP, Alavi A. Lipedema: a review of the literature. Int J Low Extrem Wounds 2015; 14 (03) 262-267
  • 16 Forner-Cordero I, Oliván-Sasot P, Ruiz-Llorca C, Muñoz-Langa J. Lymphoscintigraphic findings in patients with lipedema. Rev Esp Med Nucl Imagen Mol 2018; 37 (06) 341-348
  • 17 Shin BW, Sim YJ, Jeong HJ, Kim GC. Lipedema, a rare disease. Ann Rehabil Med 2011; 35 (06) 922-927
  • 18 Mehrara BJ, Greene AK. Lymphedema and obesity: is there a link?. Plast Reconstr Surg 2014; 134 (01) 154e-160e
  • 19 Greene AK. Diagnosis and management of obesity-induced lymphedema. Plast Reconstr Surg 2016; 138 (01) 111e-118e
  • 20 Greene AK, Grant FD, Slavin SA, Maclellan RA. Reply: obesity-induced lymphedema: clinical and lymphoscintigraphic features. Plast Reconstr Surg 2016; 137 (03) 648e
  • 21 Warren Peled A, Kappos EA. Lipedema: diagnostic and management challenges. Int J Womens Health 2016; 8: 389-395
  • 22 Patel KM, Lin CY, Cheng MH. A prospective evaluation of lymphedema-specific quality-of-life outcomes following vascularized lymph node transfer. Ann Surg Oncol 2015; 22 (07) 2424-2430
  • 23 Pusic AL, Cemal Y, Albornoz C. , et al. Quality of life among breast cancer patients with lymphedema: a systematic review of patient-reported outcome instruments and outcomes. J Cancer Surviv 2013; 7 (01) 83-92
  • 24 Chang DW. Lymphaticovenular bypass for lymphedema management in breast cancer patients: a prospective study. Plast Reconstr Surg 2010; 126 (03) 752-758
  • 25 Chang DW, Suami H, Skoracki R. A prospective analysis of 100 consecutive lymphovenous bypass cases for treatment of extremity lymphedema. Plast Reconstr Surg 2013; 132 (05) 1305-1314
  • 26 Rockson SG. Lymphedema. Am J Med 2001; 110 (04) 288-295
  • 27 Zampell JC, Yan A, Elhadad S, Avraham T, Weitman E, Mehrara BJ. CD4(+) cells regulate fibrosis and lymphangiogenesis in response to lymphatic fluid stasis. PLoS One 2012; 7 (11) e49940
  • 28 Aschen S, Zampell JC, Elhadad S, Weitman E, De Brot M, Mehrara BJ. Regulation of adipogenesis by lymphatic fluid stasis: part II. Expression of adipose differentiation genes. Plast Reconstr Surg 2012; 129 (04) 838-847
  • 29 Zampell JC, Aschen S, Weitman ES. , et al. Regulation of adipogenesis by lymphatic fluid stasis: part I. Adipogenesis, fibrosis, and inflammation. Plast Reconstr Surg 2012; 129 (04) 825-834